Five-year results of a prospective, randomised, contralateral eye trial of corneal crosslinking for keratoconus.
Jay J MeyerCharlotte A JordanDipika V PatelAkilesh GokulSimon J DeanSuheb AhmedShanu SubbiahCharles N J McgheePublished in: Clinical & experimental ophthalmology (2021)
CXL is an effective and relatively safe intervention to halt or reduce the progression of keratoconus in the majority of eyes for at least 5 years.